Study: Optimizing Cell Viability During CHO Cell Freezing

Alexander Fuchs
Alexander Fuchs

Improving Cryogenic Freezing of a Mammalian Cell Line

A study was conducted aiming to optimize the cryogenic freezing process of CHO-K1 cell line using an innovative controlled rate liquid nitrogen freezer (RoSS.LN2F). The mammalian cells were filled into 250mL single-use bags and protected by RoSS.KSET.

The study included three different freeze runs at different cooling rates in the controlled rate RoSS.LN2F, as well as an additional uncontrolled freeze run in a static freezer for comparison purposes.  

To comprehensively assess the impact of varying freezing rates on post-thaw cell recovery, the study incorporated three viability assays: Trypan blue, LIVE/DEAD and Fluorescence.

Study Results: Optimal Freezing Protocol for Cell-based Therapies

Intra-experimental variations between the different freezing runs were minor. The study suggests that a freezing rate of −1°C/min is optimal for mammalian cell lines.

However, the study also emphasized on cell survival rate for other freezing rates, as the optimal cooling rate is not limited to -1°C/min. The results show that the range of optimal cooling rates can be expanded to a certain level.

The study also highlights the importance of controlling the freezing process. What are the consequences of freezing in an uncontrolled environment, such as a static freezer, compared to a recipe-driven, standardized, and scalable controlled freezing protocol?

Preview of Single Use Support's study about cell viability

Download study

Study: Increased CHO Cell Viability with Controlled Liquid Nitrogen Freezer

The study was conducted aiming to optimize the cryogenic freezing process of the mammalian CHO-K1 cell line with an innovative controlled rate liquid nitrogen freezer (RoSS.LN2F). Cryopreservation of cells is absolutely crucial in all biotechnological processes to maintain critical biological functions of producer strains. In this study three viability assays, namely Trypan Blue, LIVE/DEAD and Fluorescence, were incorporated to comprehensively assess the impact of varying freezing rates on post-thaw cell recovery.

Alexander Fuchs
Alexander Fuchs Head of Product Innovation

Alexander is Head of Product Line Management & Product Innovation. He owns a wide range of experience and knowledge in various and different industries such as jewellery, manufacturing industry and biopharma, and multiple areas of activities due to his highly technical education and intensive insights. 

Passionate for Automation, Engineering and Process Management Alexander contributes to the innovative focus of advancing cold chain management within the biopharmaceutical industry.